Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | hALK.CAR T cells |
Synonyms | |
Therapy Description |
hALK.CAR T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting ALK linked to the CD8 alpha hinge and transmembrane domain, CD28 costimulatory domain, and CD3zeta signaling domain, which potentially induces cytoxicity against tumor cells with high Alk expression (PMID: 38039964). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
hALK.CAR T cells | hALK.CAR T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting ALK linked to the CD8 alpha hinge and transmembrane domain, CD28 costimulatory domain, and CD3zeta signaling domain, which potentially induces cytoxicity against tumor cells with high Alk expression (PMID: 38039964). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
ALK F1245C | neuroblastoma | sensitive | hALK.CAR T cells | Preclinical - Patient cell culture | Actionable | In a preclinical study, co-culture with hALK.CAR T cells induced killing of cells derived from a patient-derived xenograft (PDX) model of neuroblastoma harboring ALK F1245C in culture (PMID: 38039964). | 38039964 |
ALK F1174L | neuroblastoma | sensitive | hALK.CAR T cells | Preclinical - Cell culture | Actionable | In a preclinical study, co-culture with hALK.CAR T cells induced killing of neuroblastoma cells harboring ALK F1174L in culture (PMID: 38039964). | 38039964 |
ALK amp | neuroblastoma | sensitive | hALK.CAR T cells | Preclinical - Cell line xenograft | Actionable | In a preclinical study, co-culture with hALK.CAR T cells induced killing of neuroblastoma cells with ALK amplification in culture and inhibited tumor growth and improved tumor-free survival in a cell line xenograft model (PMID: 38039964). | 38039964 |
ALK R1275Q | neuroblastoma | sensitive | hALK.CAR T cells | Preclinical - Cell culture | Actionable | In a preclinical study, co-culture with hALK.CAR T cells induced killing of neuroblastoma cells harboring ALK R1275Q in culture (PMID: 38039964). | 38039964 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06803875 | Phase Ib/II | hALK.CAR T cells | Study of HALK.CAR T Cells for Patients with Relapsed/refractory High-risk Neuroblastoma | Not yet recruiting | USA | 0 |